Guidance for laboratories performing molecular pathology for cancer patients

Molecular testing is becoming an important part of the diagnosis of any patient with cancer. The challenge to laboratories is to meet this need, using reliable methods and processes to ensure that patients receive a timely and accurate report on which their treatment will be based. The aim of this paper is to provide minimum requirements for the management of molecular pathology laboratories. This general guidance should be augmented by the specific guidance available for different tumour types and tests. Preanalytical considerations are important, and careful consideration of the way in which specimens are obtained and reach the laboratory is necessary. Sample receipt and handling follow standard operating procedures, but some alterations may be necessary if molecular testing is to be performed, for instance to control tissue fixation. DNA and RNA extraction can be standardised and should be checked for quality and quantity of output on a regular basis. The choice of analytical method(s) depends on clinical requirements, desired turnaround time, and expertise available. Internal quality control, regular internal audit of the whole testing process, laboratory accreditation, and continual participation in external quality assessment schemes are prerequisites for delivery of a reliable service. A molecular pathology report should accurately convey the information the clinician needs to treat the patient with sufficient information to allow for correct interpretation of the resu...
Source: Journal of Clinical Pathology - Category: Pathology Authors: Tags: Open access, Editor's choice, Molecular biology Best practice Source Type: research

Related Links:

The fasting mimicking diet is, in essence, a clever strategy to pull in significant funding for the rigorous study of the use of forms of calorie restriction as a therapy. A fasting mimicking diet involves taking in just few enough calories to trigger most of the benefits of fasting. There must exist a dividing line in calorie intake at which nutrient sensor mechanisms determine that the body is in a state of fasting. Early research into fasting mimicking found that dividing line to be somewhere in the vicinity of 500 to 750 calories daily, but later studies use lower calorie levels. Another important point of calibration ...
Source: Fight Aging! - Category: Research Authors: Tags: Medicine, Biotech, Research Source Type: blogs
Chem. Commun., 2021, Advance Article DOI: 10.1039/D1CC05864A, CommunicationWen-Xin Wang, Wen-Li Jiang, Guo-Jiang Mao, Zhi-Ke Tan, Min Tan, Chun-Yan Li A novel theranostic probe called CX-B-DF is constructed for chemotherapy guided by near-infrared (NIR) fluorescence imaging. Moreover, the accuracy of drug release is improved under dual activation (H2O2 and TP). To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Chem. Commun. latest articles - Category: Chemistry Authors: Source Type: research
The Food and Drug Administration approved rituximab in combination with chemotherapy for the treatment of pediatric patients with 4 different types of previously untreated, advanced stage blood cancers.FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
Early implementation of federal transparency mandates for hospital prices illustrate challenges consumers and companies will face in trying to use these data to control costs.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Biomedical Engineering Scientific Interest Group Dr. Fischbach is the Stanley Bryer 1946 Professor of Biomedical Engineering at Cornell University, Director of Cornell's Physical Sciences Oncology Center on the Physics of Cancer Metabolism, and Associate Director of Cornell Nanoscale Science and Engineering Facility. Dr. Fischbach will review the compositional, microarchitectural, and mechanical hallmarks of the pro-tumorigenic extracellular matrix (ECM) and highlight biomaterials and engineering approaches to recapitulate these properties for in vitro and in vivo studies of cancer. She also will describe how such engineer...
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video
Conditions:   Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8;   Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Interventions:   Procedure: Surgery with or without Neck Dissection;   Radiation: Radiation;   Drug: Cisplatin based chemotherpay Sponsors:   Tata Memorial Centre;   All India Institute of Medical Sciences, New Delhi;   Amrita Institute of Medical Sciences&Research Center Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Conditions:   Metastatic Cancer;   Metastatic Breast Cancer;   Metastatic Pancreatic Cancer;   Metastatic Gastric Cancer;   Metastatic Lung Cancer;   Metastatic Ovary Cancer;   Oesophageal Cancer;   Endometrial Cancer;   Advanced Solid Tumor Intervention:   Drug: IPH5301 ALONE OR IN COMBINATION WITH CHEMOTHERAPY AND TRASTUZUMAB Sponsors:   Institut Paoli-Calmettes;   Innate Pharma Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Condition:   Thoracic Cancer Intervention:   Device: AEON Endostapler Sponsor:   Lexington Medical Inc. Completed
Source: - Category: Research Source Type: clinical trials
Condition:   Breast Cancer Interventions:   Drug: Alpelisib;   Drug: Sacituzumab govitecan Sponsors:   University of Kansas Medical Center;   Novartis Pharmaceuticals;   Gilead Sciences Not yet recruiting
Source: - Category: Research Source Type: clinical trials
An experimental PET radiotracer is safe and appears effective for detectin...Read more on AuntMinnie.comRelated Reading: PET tracer proves effective for assessing immunotherapy Quitting smoking slows early lung cancer progression CT identifies candidates for sublobar resection for lung cancer CT radiomics predicts survival in NSCLC patients Falling lung cancer rates drive cancer decline in U.S.
Source: Headlines - Category: Radiology Source Type: news
More News: Biology | Cancer | Cancer & Oncology | Laboratory Medicine | Molecular Biology | Nutrition | Pathology